Evaluation of Pharmaceutical Intervention at Hepatitis C Medication Therapy Adherence Clinic in North Borneo, Malaysia (Epic MTAC)

Authors

  • Bee Keng Law Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia
  • Euginie Tracy Wong Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia
  • Qiao Wei Liew Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia
  • Zhi Sam Heng Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia

DOI:

https://doi.org/10.51200/bjms.v14i.2318

Keywords:

pharmacist, hepatitis C, pharmaceutical intervention, Medication Therapy Adherence Clinic (MTAC), Sustained Virological Response (SVR)

Abstract

Introduction: Hepatitis C virus (HCV) is a worrying public health issue worldwide. The introduction of direct-acting antiviral agents (DAAs) brings revolution to HCV treatment. Pharmacists’ role in Malaysia is significant since the implementation of Medication Therapy Adherence Clinic (MTAC). This study aims to determine the sustained virological response (SVR12) for HCV patients treated with Sofosbuvir and Daclatasvir and/or Ribavirin. Besides, it evaluates adherence rate, types of pharmaceutical intervention and physicians’ acceptance rate.

Downloads

Additional Files

Published

2020-03-30

How to Cite

Law, B. K., Wong, E. T., Liew, Q. W., & Heng, Z. S. (2020). Evaluation of Pharmaceutical Intervention at Hepatitis C Medication Therapy Adherence Clinic in North Borneo, Malaysia (Epic MTAC). Borneo Journal of Medical Sciences (BJMS), (1), 9. https://doi.org/10.51200/bjms.v14i.2318

Issue

2020: BORNEO JOURNAL OF MEDICAL SCIENCES (BJMS), (Suppl.), MARCH 2020

Section

Abstracts

License

The copyright of the article belongs to the authors, who retain ownership of their work published in the journal. Their work is distributed under the CC BY-NC 4.0 license

Crossref
Scopus
Google Scholar
Europe PMC
Total Views: 374 | Total Downloads: 0 | Total Downloads: 182